Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes

Rearrangements of our genome can be responsible for inherited as well as sporadic traits. The analyses of chromosome breakpoints in the proximal short arm of Chromosome 17 (17p) reveal nonallelic homologous recombination (NAHR) as a major mechanism for recurrent rearrangements whereas nonhomologous end-joining (NHEJ) can be responsible for many of the nonrecurrent rearrangements. Genome architectural features consisting of low-copy repeats (LCRs), or segmental duplications, can stimulate and mediate NAHR, and there are hotspots for the crossovers within the LCRs. Rearrangements introduce variation into our genome for selection to act upon and as such serve an evolutionary function analogous to base pair changes. Genomic rearrangements may cause Mendelian diseases, produce complex traits such as behaviors, or represent benign polymorphic changes. The mechanisms by which rearrangements convey phenotypes are diverse and include gene dosage, gene interruption, generation of a fusion gene, position effects, unmasking of recessive coding region mutations (single nucleotide polymorphisms, SNPs, in coding DNA) or other functional SNPs, and perhaps by effects on transvection.

[1]  J. Lupski,et al.  Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect , 2006, Annals of neurology.

[2]  P. Stankiewicz,et al.  Trisomy 17p10‐p12 due to mosaic supernumerary marker chromosome: Delineation of molecular breakpoints and clinical phenotype, and comparison to other proximal 17p segmental duplications , 2005, American journal of medical genetics. Part A.

[3]  J. Lupski,et al.  Phenotypic consequences of genetic variation at hemizygous alleles: Sotos syndrome is a contiguous gene syndrome incorporating coagulation factor twelve (FXII) deficiency , 2005, Genetics in Medicine.

[4]  P. Stankiewicz,et al.  Interphase FISH screening for the LCR‐mediated common rearrangement of isochromosome 17q in primary myelofibrosis , 2005, American journal of hematology.

[5]  E. Eichler,et al.  Segmental duplications and copy-number variation in the human genome. , 2005, American journal of human genetics.

[6]  J. Lupski,et al.  Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. , 2005, Human molecular genetics.

[7]  P. Stankiewicz,et al.  Position effects due to chromosome breakpoints that map ∼900 Kb upstream and ∼1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia , 2005 .

[8]  K. Devriendt,et al.  RAI1 variations in Smith–Magenis syndrome patients without 17p11.2 deletions , 2005, Journal of Medical Genetics.

[9]  B. Rovin,et al.  The Influence of CCL 3 L 1 Gene – Containing Segmental Duplications on HIV-1 / AIDS Susceptibility , 2009 .

[10]  H. Stefánsson,et al.  A common inversion under selection in Europeans , 2005, Nature Genetics.

[11]  J. Lupski,et al.  Chapter 70 – Hereditary Motor and Sensory Neuropathies Involving Altered Dosage or Mutation of PMP22: The CMT1A Duplication and HNPP Deletion , 2005 .

[12]  P. Stankiewicz,et al.  Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia. , 2005, American journal of human genetics.

[13]  D. Kleinjan,et al.  Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.

[14]  J. Lupski,et al.  Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome. , 2004, Human molecular genetics.

[15]  E. Lander,et al.  Finishing the euchromatic sequence of the human genome , 2004 .

[16]  C. Ponting,et al.  Finishing the euchromatic sequence of the human genome , 2004 .

[17]  J. Bonfield,et al.  Finishing the euchromatic sequence of the human genome , 2004, Nature.

[18]  N. Carter,et al.  Applications of genomic microarrays to explore human chromosome structure and function. , 2004, Human molecular genetics.

[19]  J. Lupski,et al.  Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome , 2004, Human Genetics.

[20]  David N Cooper,et al.  Breakpoints of gross deletions coincide with non-B DNA conformations. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Lupski,et al.  Hotspots of homologous recombination in the human genome: not all homologous sequences are equal , 2004, Genome Biology.

[22]  N. Carter.  As normal as normal can be? , 2004, Nature Genetics.

[23]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[24]  Kenny Q. Ye,et al.  Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.

[25]  J. Lupski,et al.  Uncommon deletions of the Smith-Magenis syndrome region can be recurrent when alternate low-copy repeats act as homologous recombination substrates. , 2004, American journal of human genetics.

[26]  Dana C Crawford,et al.  Evidence for substantial fine-scale variation in recombination rates across the human genome , 2004, Nature Genetics.

[27]  S. Keeney,et al.  Where the crossovers are: recombination distributions in mammals , 2004, Nature Reviews Genetics.

[28]  P. Donnelly,et al.  The Fine-Scale Structure of Recombination Rate Variation in the Human Genome , 2004, Science.

[29]  X. Estivill,et al.  Small marker chromosomes in two patients with segmental aneusomy for proximal 17p , 2004, Human Genetics.

[30]  J. Lupski,et al.  Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. , 2004, Human molecular genetics.

[31]  M. Fontès,et al.  Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease , 2004, Nature Medicine.

[32]  J. Lupski,et al.  Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2). , 2003, Human molecular genetics.

[33]  Christina A. Cuomo,et al.  The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats. , 2004, American journal of human genetics.

[34]  J. Lupski,et al.  Non-recurrent 17p11.2 deletions are generated by homologous and non-homologous mechanisms , 2004, Human Genetics.

[35]  J. Lupski,et al.  Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2. , 2003, American journal of human genetics.

[36]  K. Nave,et al.  Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) , 2003, Nature Medicine.

[37]  P. Stankiewicz,et al.  Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)] , 2003, Genetics in Medicine.

[38]  E. Eichler,et al.  An Alu transposition model for the origin and expansion of human segmental duplications. , 2003, American journal of human genetics.

[39]  J. Lupski,et al.  Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) Contiguous Gene Syndromes by Chromosome Engineering in Mice: Phenotypic Consequences of Gene Dosage Imbalance , 2003, Molecular and Cellular Biology.

[40]  L. Shaffer,et al.  Genome architecture catalyzes nonrecurrent chromosomal rearrangements. , 2003, American journal of human genetics.

[41]  Xavier Estivill,et al.  Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions. , 2003, Human molecular genetics.

[42]  C. Vlangos,et al.  Mutations in RAI1 associated with Smith–Magenis syndrome , 2003, Nature Genetics.

[43]  J. Lupski.  2002 Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture. , 2003, American journal of human genetics.

[44]  J. Lupski,et al.  Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2. , 2002, American journal of human genetics.

[45]  L. Shaffer,et al.  Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. , 2002, American journal of human genetics.

[46]  Dagmar Wieczorek,et al.  Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters mediate the recurrent t(4;8)(p16;p23) translocation. , 2002, American journal of human genetics.

[47]  B. Birren,et al.  Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs. , 2002, Genome research.

[48]  G. Danieli,et al.  Analysis of 22 deletion breakpoints in dystrophin intron 49 , 2002, Human Genetics.

[49]  P. Stankiewicz,et al.  Genome architecture, rearrangements and genomic disorders. , 2002, Trends in genetics : TIG.

[50]  E. Eichler,et al.  Recent duplication, domain accretion and the dynamic mutation of the human genome. , 2001, Trends in genetics : TIG.

[51]  P. Stankiewicz,et al.  Trisomy 17p10‐p12 resulting from a supernumerary marker chromosome derived from chromosome 17: molecular analysis and delineation of the phenotype , 2001, Clinical genetics.

[52]  Stephen W. Scherer,et al.  A 1.5 million–base pair inversion polymorphism in families with Williams-Beuren syndrome , 2001, Nature Genetics.

[53]  B. Trask,et al.  Segmental duplications: organization and impact within the current human genome project assembly. , 2001, Genome research.

[54]  L. Shaffer,et al.  Molecular mechanism for duplication 17p11.2— the homologous recombination reciprocal of the Smith-Magenis microdeletion , 2000, Nature Genetics.

[55]  Å. Borg,et al.  Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. , 1999, Blood.

[56]  L. Shaffer,et al.  Proteolipid protein gene duplications causing Pelizaeus‐Merzbacher disease: Molecular mechanism and phenotypic manifestations , 1999, Annals of neurology.

[57]  C. Tyler-Smith,et al.  A selective difference between human Y-chromosomal DNA haplotypes , 1998, Current Biology.

[58]  J. Lupski.  Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. , 1998, Trends in genetics : TIG.

[59]  J. Lupski,et al.  A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element , 1998, Nature Genetics.

[60]  Gerald R. Smith.  Chi Sites and Their Consequences , 1998 .

[61]  A. C. Chinault,et al.  Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome , 1997, Nature Genetics.

[62]  B. Trask,et al.  Quantification by flow cytometry of chromosome-17 deletions in Smith-Magenis syndrome patients , 1996, Human Genetics.

[63]  F Greenberg,et al.  Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients. , 1996, American journal of human genetics.

[64]  C McCluggage,et al.  Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) , 1996, American journal of medical genetics.

[65]  J. Lupski,et al.  The Smith-Magenis syndrome [del(17)p11.2]: Clinical review and molecular advances , 1996 .

[66]  J. Lupski,et al.  Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. , 1994, Human molecular genetics.

[67]  Stylianos E. Antonarakis,et al.  Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A , 1993, Nature Genetics.

[68]  J. Lupski,et al.  Conservation and evolution of the rpsU‐dnaG‐rpoD macromolecular synthesis operon in bacteria , 1993, Molecular microbiology.

[69]  C. Disteche,et al.  DNA deletion associated with hereditary neuropathy with liability to pressure palsies , 1993, Cell.

[70]  A. C. Chinault,et al.  Charcot–Marie–Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit , 1992, Nature Genetics.

[71]  J. Lupski,et al.  Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2). , 1991, American journal of human genetics.

[72]  Aravinda Chakravarti,et al.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.

[73]  R. Liskay,et al.  Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology , 1988, Molecular and cellular biology.

[74]  A. Letsou,et al.  Homology requirement for efficient gene conversion between duplicated chromosomal sequences in mammalian cells. , 1987, Genetics.

[75]  R. Pauli,et al.  Interstitial deletion of (17)(p11.2p11.2): report of six additional patients with a new chromosome deletion syndrome. , 1986, American journal of medical genetics.

[76]  J. Opitz,et al.  Interstitial deletion of (17)(p11.2p11.2) in nine patients. , 1986, American journal of medical genetics.